39615-41-3

Upstream product

• 108-86-1 bromobenzene 
• 5447-86-9 10,10-dimethyl-9,10-dihydroanthracen-9-one 
• 100-59-4 phenylmagnesium chloride 

Downstream Products

• 123613-81-0 2-(2-benzoyl-α,α-dimethylbenzyl)phenol 
• 13577-30-5 9-Aethoxy-10,10-dimethyl-9-phenyl-9,10-dihydro-anthracen 

Relevant academic research and scientific papers

Dimethylanthracene organic compound and application thereof in OLED (organic light emitting diode) device

The invention relates to dimethyl anthracene organic compounds and an application thereof to an OLED (organic light emitting diode) device. The structure of the compounds is that dimethyl anthracene is linked with a carbazole ring structure or a benzo six-membered ring structure through C-C bonds, the chemical stability of the material is improved and exposure of branch group active positions is avoided through linking of the C-C bonds, and the whole molecule is a larger rigid structure and has high triplet state energy level (T1); the compounds have large steric hindrance, cannot be rotated easily and have more stable stereoscopic space structure and thus have higher glass transition temperature and molecular heat stability. Besides, the HOMO and LUMO distribution positions of the compounds are separated, so that the compounds have proper HOMO and LUMO energy levels. Thus, the compounds can effectively improve the luminous efficiency and prolong the service life of the device effectively after being applied to the OLED device.

Organic electroluminescent compound as well as preparation method and apparatus thereof

The invention relates to the field of light-emitting materials, in particular to an organic electroluminescent compound as well as a preparation method and an apparatus thereof. In order to solve theproblem in the conventional hole-transport material to o

Dimethyl anthracene organic compound, and application thereof on organic light-emitting device

The invention relates to a dimethyl anthracene organic compound, and application thereof on an organic light-emitting device. A structure of the compound is characterized in that dimethyl anthracene is connected with a carbazole parallel loop structure through a carbon-carbon bond; with the carbon-carbon bond connection, the chemical stability of the material is improved, and an active position ofa branch perssad is prevented from being exposed; in addition, the whole molecule is of a larger rigid structure, has a high triplet state energy level (T1), and is large in steric hindrance, not easy to rotate, and more stable in three-dimensional space structure, so that the compound has higher glass state temperature and molecular heat stability; in addition, distribution positions of HOMO andLUMO of the compound provided by the invention are separated, so that the compound has appropriate HOMO and LUMO energy levels; therefore, after the compound provided by the invention is applied to the OLED (Organic Light-emitting Diode) device, the light-emitting efficiency and the service life of the device can be effectively improved.

Tricylic amino-acid derivatives

Described herein are compounds which have the general formula: or a prodrug or pharmaceutically acceptable salt, solvate or hydrate thereof wherein: R1 is selected from the group consisting of H, alkyl and the counter ion for a basic addition salt; X is selected from the group consisting of CR9R10, S, O, SO, SO2, NH and N-alkyl; R2, R3, R4, R9 and R10 are independently selected from the group consisting of H and alkyl; R5 and R6 are independently selected from the group consisting of H, alkyl and phenyl, or, alternatively, R5 and R6 together may form a methylene group or a 3- to 6-membered a spirocyclic group; wherein, when X is CR9R10, one or both pairs of R5 and R9 or R6 and R10 may join to form a double or triple bond R7 is selected from the group consisting of Formula II-V: which are all optionally substituted, at nodes other than R8, with 1-4 substituents independently selected from the group consisting of alkyl, halo, aryl (which may be substituted as for R8), trifluoromethyl, trifluoromethoxy, nitro, cyano, amino, mono-alkylamino, di-alkylamino, alkoxycarbonyl, alkylcarbonyl, alkoxythiocarbonyl, alkylthiocarbonyl, alkoxy, alkylS-, phenoxy, -SO2NH2, -SO2NHalkyl, -SO2N(alkyl)2 and 1,2-methylenedioxy; and wherein any of the benzo-fused rings in structures II to V may be replaced by a 5- or 6-membered heterocyclic ring selected from the group consisting of pyridine, thiophene, furan and pyrrole; wherein R8 is selected from the group consisting of H, alkyl, benzyl, cycloalkyl, indanyl and an optionally substituted aryl group, wherein the optional substituents are independently selected from 1-4 members of the group consisting of alkyl, halo, aryl, trifluoromethyl, trifluoromethoxy, nitro, cyano, amino, mono-alkylamino, di-alkylamino, alkoxycarbonyl, alkylcarbonyl, alkoxythiocarbonyl, alkylthiocarbonyl, alkoxy, alkylS-, phenoxy, -SO2NH2, -SO2NHalkyl, -SO2N(alkyl)2 and 1,2-methylenedioxy; -represents a single or double bond; Y is selected from the group consisting of O, S, SO, NH, N-alkyl, CH2, CH-alkyl, C(alkyl)2, and C=O; Z is selected from the group consisting of CH2, O, S, NH and N-alkyl when-is a single bond; Z is selected from the group consisting of CH and N when-is a double bond. Also described is the use of these compounds as pharmaceuticals.